General Information


DRAVP ID  DRAVPe01604

Peptide Name   CCR5 ECL2 (168-191)

Sequence  RSQKEGLHYTCSSHFPYSQYQFWK

Sequence Length  24

UniProt ID  P51681 

Source  Synthetic construct



Activity Information


Target Organism  HIV

Assay  HIV neutralization assay

Activity 

  • [Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=136 ± 49 μM);
  • HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=138± 36 μM);
  • HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=89±31 μM);
  • HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=103±37 μM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  gp120

Mechanism  The peptide binds gp120 and inhibits virus entry.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe01604

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C138H191N37O38S

Absent amino acids  ADIMNV

Common amino acids  S

Mass  3008.32

Pl  9.05

Basic residues  5

Acidic residues  1

Hydrophobic residues  4

Net charge  4

Boman Index  -5993

Hydrophobicity  -131.25

Aliphatic Index  16.25

Half Life 

  •     Mammalian:1 hour
  •     Yeast:2 min
  •     E.coli:2 min

Extinction Coefficient cystines  9970

Absorbance 280nm  433.48

Polar residues  10



Literature Information


Literature 1

Title   Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.

Pubmed ID   22403408

Reference   J Biol Chem. 2012 Apr 27;287(18):15076-86.

Author   Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA.

DOI   10.1074/jbc.M111.332361